Results 151 to 160 of about 275,080 (334)
Clinical Pharmacology in Drug Development, EarlyView.Abstract Aripiprazole once‐monthly (AOM) is approved for the maintenance monotherapy treatment of bipolar I disorder (BP‐I) in adults. A previously developed population pharmacokinetic model was validated by applying it to data from patients diagnosed with BP‐I.
Xiaofeng Wang +10 more
wiley +1 more source
A Rapid and Simple Method for the Quantification in Human Plasma of Tricyclic Antidepressant Drugs Taken in Overdose [PDF]
, 1979 W. D. Mitchell +2 more
openalex +1 more source
ChemPlusChem, EarlyView.1,2,4‐triazole and oxadiazole motifs are synthesized from thiocarbamoylimidates precursors, under mild conditions (40 °C) in the environmentally friendly water/ethanol reaction medium. The reaction is highly versatile and allows for the introduction of a wide variety of functional groups.
Oumaima Gatri +5 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Getting the balance right: Established and emerging therapies for major depressive disorders
Neuropsychiatric Disease and Treatment, 2010 Bojana Perovic, Marija Jovanovic, Branislava Miljkovic, Sandra VezmarDepartment of Pharmacokinetics, Faculty of Pharmacy, University of Belgrade, SerbiaAbstract: Major depressive disorder (MDD) is a common and serious illness of our times, associated ...
Bojana Perovic +3 more
doaj
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs. [PDF]
, 1978 C. Burgess, Paul Turner, J Wadsworth
openalex +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.This study assessed the use of 35 pharmacogenomic (PGx) medications listed in the Royal College of Pathologists of Australasia (RCPA) guideline, estimated the potential costs of subsidizing PGx testing in Australia, and predicted related prescribing changes.
Bella D. Ianni +3 more
wiley +1 more source
CARDIAC EFFECTS OF ANTIDEPRESSANTS [PDF]
, 1972 E Marmo, L Coscia, Samuela Cataldi
openalex +1 more source
Clinical Pharmacology &Therapeutics, EarlyView.CYP2D6 alleles with low frequency in Eurocentrically biased study populations are often excluded from pharmacogenetic investigation and consequently may have misassigned activity values. This health inequity may be contributing to imprecise dose predictions for CYP2D6‐metabolizing drugs.
Oyinlade Kehinde +6 more
wiley +1 more source
Medicaid spending burden among beneficiaries with treatment-resistant depression. [PDF]
, 2019 AIM: To evaluate Medicaid spending and healthcare resource utilization (HRU) in treatment-resistant depression (TRD). MATERIALS & METHODS: TRD beneficiaries were identified from Medicaid claims databases (January 2010-March 2017) and matched 1:1 with ...
Greenberg, Paul E. +7 more
core +1 more source